All News

    Patritumab Deruxtecan BLA Withdrawn in Non-Small Cell Lung Cancer

    May 29th 2025, 4:16pm

    Article

    The BLA seeking accelerated approval for patritumab deruxtecan in previously treated, locally advanced EGFR-mutated NSCLC in the U.S. has been withdrawn.

    FDA Grants Priority Review to Sevabertinib NDA in HER2+ Lung Cancer

    May 29th 2025, 3:00pm

    Article

    The FDA has accepted and granted priority review to an NDA for sevabertinib in previously treated HER2+ non-small cell lung cancer.

    Personalizing Prostate Cancer Care With Genetic Testing, PARP Inhibitors

    May 29th 2025, 1:00pm

    Article

    Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining treatment with PARP inhibitors.

    Expanding Access to Screening May Help Prevent Esophageal Cancer

    May 28th 2025, 8:00pm

    Video

    Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer.

    HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds

    May 28th 2025, 7:00pm

    Article

    Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, including GIST and some leukemias.

    Rebuilding Resilience: Navigating Aging and Exercise After CLL

    May 28th 2025, 5:00pm

    Article

    After running the Boston Marathon at 67, I faced new limits from aging and chronic lymphocytic leukemia — but I’ve found ways to stay strong and resilient.

    Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer

    May 28th 2025, 4:19pm

    Article

    ATR-04 therapy is being investigated in the phase 1/2 ATR04-484 clinical trial for the treatment of EGFR inhibitor-associated rashes in lung cancer.

    Neoadjuvant Efti/Keytruda Combo Improves Tumor Fibrosis Rates in Sarcoma

    May 28th 2025, 3:00pm

    Article

    Neoadjuvant efti and Keytruda plus radiotherapy met the EFTISARC-NEO trial's primary end point by improving tumor fibrosis in soft tissue sarcoma.

    Radiation Therapy Eases Symptoms and Improves Targeting in Lung Cancer

    May 28th 2025, 1:00pm

    Article

    Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with modern techniques.

    The Dawn of AI in Prostate Cancer Care

    May 27th 2025, 9:00pm

    Article

    A powerful new ally is emerging in cancer care: artificial intelligence.